Showing results (861-870 of 5,689) with videos related to

Sort By:
Pageof 569
The Oncologist|June 12, 2016
Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature ReviewCarlos Andrés Ossa, Diana Torres
The Oncologist|June 12, 2016
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Ana M Molina, Yulia Lakhman, et al.
The Oncologist|June 4, 2016
Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian CancerKathleen N Moore, Bradley J Monk
The Oncologist|June 4, 2016
Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular CarcinomaSafi Shahda, Patrick J Loehrer, Romnee S Clark, et al.
The Oncologist|November 22, 2017
Ovarian and Uterine Functions in Female Survivors of Childhood CancersOzgur Oktem, Samuel S Kim, Ugur Selek, et al.
The Oncologist|November 22, 2017
Perception of Curability Among Advanced Cancer Patients: An International Collaborative StudySriram Yennurajalingam, Luis Fernando Rodrigues, Omar Shamieh, et al.
The Oncologist|November 22, 2017
Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive ComputingNirali M Patel, Vanessa V Michelini, Jeff M Snell, et al.
The Oncologist|December 8, 2017
Decision-Making Capacity for Chemotherapy and Associated Factors in Newly Diagnosed Patients with Lung CancerAsao Ogawa, Kyoko Kondo, Hiroyuki Takei, et al.
The Oncologist|December 21, 2017
Extreme Prostate-Specific Antigen Response to Infusional 5-Flourouracil in Castrate-Resistant Prostate CancerCharlotte Manogue, Elisa Ledet, A Kumar Guddati, et al.
The Oncologist|December 21, 2017
Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of VaterPat Gulhati, Kanwal Raghav, Rachna Shroff, et al.
Pageof 569